| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.002 |